Choosing the appropriate treatment setting: which information and decision-making needs do adult inpatients with mental disorders have? A qualitative interview study

Laura Kivelitz,1 Martin Härter,1 Jil Mohr,1 Hanne Melchior,1 Lutz Goetzmann,2 Max Holger Warnke,3 Silke Kleinschmidt,4 Jörg Dirmaier1 1Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 2Department of Psychosomatic Medicine and Psychotherapy, Segeberg Hospital, Bad Segeberg, Germany; 3Specialist Clinic for Psychosomatic Medicine and Psychotherapy, MediClin Seepark Klinik, Bad Bodenteich, Germany; 4Specialist Clinic for Psychosomatic Medicine and Psychotherapy, Curtius Klinik, Bad Malente-Gremsmühlen, Germany Background: Decisions on medical treatment setting are perceived as important but often difficult to make for patients with mental disorders. Shared decision-making as a strategy to decrease decisional conflict has been recommended, but is not yet widely implemented. This study aimed to investigate the information needs and the decision-making preferences of patients with mental disorders prior to the decision for a certain treatment setting. The results will serve as a prerequisite for the development of a high-quality patient decision aid (PtDA) regarding the treatment setting decision. Methods: We conducted retrospective individual semi-structured interviews with n=24 patients with mental disorders in three psychotherapeutic inpatient care units. The interviews were audiotaped, transcribed, coded, and content-analyzed. Results: The majority of the patients wanted to be involved in the decision-making process. They reported high information needs regarding treatment options in order to feel empowered to participate adequately in the decision for a certain treatment setting. However, some patients did not want to participate or receive information, for example, because of their high burden of mental disorder. Whereas the majority were satisfied with the extent they were involved in the decision, few participants felt sufficiently informed about treatment options. Most patients reported that a decision aid regarding an appropriate treatment setting would have been helpful for them. Important information that should be included in a PtDA was general information about mental illness, effective treatment options, specific information about the different treatment settings, and access to treatment. Discussion: The identified information and decision-making needs provide a valuable basis for the development of a PtDA aiming to support patients and caregivers regarding the decision for an adequate treatment setting. As preferences for participation vary among patients and also depend on the current mental state, a flexible approach is needed to meet patients’ individual wishes and needs. Keywords: mental disorders, needs assessment, psychotherapy, treatment decision, treatment setting, shared decision-making, qualitative interview

Assessment of late gadolinium enhancement in nonischemic cardiomyopathy: comparison of a fast Phase-Sensitive Inversion Recovery Sequence (PSIR) and a conventional segmented 2D gradient echo recall (GRE) sequence-preliminary findings

BACKGROUND: Reliable detection of myocardial scarring in nonischemic cardiomyopathy is time-consuming using techniques that require determination of optimal inversion time. Therefore we evaluated an inversion-time-insensitive approach using a fast phase-sensitive inversion recovery (PSIR) sequence to detect and quantify late gadolinium enhancement (LGE). PATIENTS AND METHODS: Twenty patients (mean age 40 years, 9 females) with nonischemic cardiomyopathy and evidence of LGE were evaluated. After administration of 0.2 mmol/kg gadolinium diethylene triamine pentaacetic acid, a segmented 2D inversion recovery turbo fast low-angle shot gradient echo recall (GRE) sequence [echo time (TE) 4.3 milliseconds, repetition time (TR) 750 milliseconds, alpha 30 degrees, voxel size 1.7 x 1.3 x 8-10 mm] was obtained and served as the standard of reference. Second, a fast multislice single-shot 2D PSIR sequence (TE 1.1 millisecond, TR 700 milliseconds, alpha 40 degrees , voxel size 2.5 x 1.7 x 8-10 mm) was acquired in the same slice positions. The PSIR(IR) images were used to analyze LGE. Altogether 53 short-axis slices with LGE were evaluated. Contrast-to-noise ratio and area of LGE were calculated and compared by 2 experienced readers. Image quality and confidence level for identification of LGE were rated on 5-point scales. Interobserver variability was evaluated in 10 patients. RESULTS: All images were interpretable. Imaging time was reduced from 385 +/- 127 seconds to 20 +/- 3 seconds (P < 0.001). Contrast-to-noise ratio was 8.29 for PSIRmag and 12.07 for the conventional GRE images (P < 0.001). The mean area of LGE was 1.01 +/- 0.62 cm(2) for the GRE sequence and 1.10 +/- 0.62 cm(2) for PSIR(IR) (P = NS). The general linear model showed no interaction between the results and no significant difference of the mean (r = 0.09, mean difference 0.09 cm(2)). The overall interobserver variability of PSIR(IR) and GRE was excellent, with Pearson's correlation coefficients of r = 0.96 for PSIR(IR) and r = 0.98 for GRE. PSIR(IR) and conventional GRE were comparable in terms of image quality and confidence level (image quality: 1.6 +/- 0.67 vs. 1.5 +/- 0.93, P = NS; confidence level: 1.4 +/- 0.84 vs. 1.3 +/- 0.5; P = NS). CONCLUSIONS: Fast PSIR sequences enable accurate detection and quantification of LGE in nonischemic cardiomyopathies. The examination time can be significantly shortened using the single-shot approach of the PSIR technique